Diana-alexandra Ertl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia.
Journal: European journal of endocrinology
Published: April 27, 2026
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.
Journal: European journal of endocrinology
Published: January 09, 2026
Burosumab prevents further height deficit in toddlers affected by XLH.
Journal: Endocrine connections
Published: July 15, 2025
Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry.
Journal: JBMR plus
Published: March 07, 2025
Growth Hormone Therapy: Comparison of Short- and Long-Term Outcomes between Children with Growth Hormone Deficiency and Small for Gestational Age.
Journal: Hormone research in paediatrics
Published: February 02, 2024
Successful Use of Metyrapone Suppositories in an Infant with Neonatal Cushing and McCune Albright Syndrome: A Case Report.
Journal: Hormone research in paediatrics
Published: June 20, 2023
Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome.
Journal: European journal of hospital pharmacy : science and practice
Published: May 23, 2023
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
Journal: European journal of endocrinology
Published: April 21, 2023
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
Journal: European journal of endocrinology
Published: March 29, 2023
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.
Journal: Journal of endocrinological investigation
Published: September 08, 2022
Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study.
Journal: Orphanet journal of rare diseases
Published: August 24, 2022
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone.
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone.
Journal: Orphanet journal of rare diseases
Published: May 31, 2022
Last Updated: 09/26/2026